Product Information

TETRABENAZINE 12.5 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.6425 per EA under NDC 23155093863. Its NADAC has been published 42 times since Feb 4, 2026.

FDA first approved this application on Jan 22, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TETRABENAZINE 12.5 MG TABLET

Tetrabenazine
$0.6425per EA

Strength

12.5 mg/1

NDC

23155093863

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TETRABENAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA213316

FDA Approved

1/22/2020

TE Code

AB

On Market Since

9/1/2025

Pharmacological Classes

Vesicular Monoamine Transporter 2 Inhibitor
Vesicular Monoamine Transporter 2 Inhibitors

Price Statistics

The NADAC for TETRABENAZINE 12.5 MG TABLET has been published 42 times since Feb 4, 2026, and over the history we have for it it has declined 18.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6425 per EA
All-time high$0.8066 (Jul 15, 2026)
All-time low$0.6425 (Nov 18, 2026)
52-week high$0.8066
52-week low$0.6425
Median price$0.7854
Average price$0.7652
Largest weekly change-7.7% (Sep 23, 2026)
Weeks tracked42
Tracking sinceFeb 4, 2026

Price History

1W

-4.7%

1M

-8.5%

3M

-15.5%

6M

-20.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

-18.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TETRABENAZINE 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 12.5 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.6425 per EA (NDC 23155093863), effective Nov 18, 2026.

How has the price of TETRABENAZINE 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TETRABENAZINE 12.5 MG TABLET has declined 18.0%. It has been tracked across 42 weekly CMS publications since Feb 4, 2026.

What are the highest and lowest recorded NADAC prices for TETRABENAZINE 12.5 MG TABLET?

Since Feb 4, 2026, the NADAC for TETRABENAZINE 12.5 MG TABLET has ranged from a low of $0.6425 (Nov 18, 2026) to a high of $0.8066 (Jul 15, 2026), with a median of $0.7854 per EA.

Are there cheaper alternatives to TETRABENAZINE 12.5 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TETRABENAZINE 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TETRABENAZINE 12.5 MG TABLET?

TETRABENAZINE 12.5 MG TABLET (NDC 23155093863) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.